Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades

Journal of Cerebral Blood Flow and Metabolism

Volumn 22, Issue 5, 2002, Pages 503-514

  Chong, Zhao Zhong ^a   Kang, Jing Qiong ^a   Maiese, Kenneth ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cysteine proteases; Hypoxia inducible factor; Janus tyrosine kinase; Mitogen activated protein kinases; Protein kinase B

Indexed keywords

CYSTEINE PROTEINASE; DNA; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HEMOPOIETIC GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MEMBRANE PHOSPHOLIPID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLSERINE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE; STAT5 PROTEIN;

APOPTOSIS; CELL MEMBRANE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; DNA DEGRADATION; DRUG MECHANISM; MEMBRANE PERMEABILITY; MEMBRANE STRUCTURE; MITOCHONDRIAL MEMBRANE; MODEL; MOLECULAR MECHANICS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0036244550     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200205000-00001     Document Type: Review

References (121)

1. Erythropoietin: A principal modulator of ischemic cerebrovascular endothelial cell programmed cell death
2. Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway
3. Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage
4. Direct effect of erythropoietin on rat vascular smooth-muscle cell via a putative erythropoietin receptor
5. Erythropoietin receptor mRNA expression in human endothelial cells
6. Endothelial apoptosis induced by oxidative stress through activation of nf-kappab: Antiapoptotic effect of antioxidant agents on endothelial cells
7. The cleavage of Akt/protein kinase B by death receptor signaling is an important event in detachment-induced apoptosis
8. A potential role for erythropoietin in focal permanent cerebral ischemia in mice
9. cDNA cloning and functional analysis of a truncated STAT5a protein from autonomously growing FDCP-1 cells
10. Activation of the transcription factor NF-kappaB by the erythropoietin receptor: Structural requirements and biological significance
11. Apoptotic vascular endothelial cells become procoagulant
12. Nitric oxide, cytochrome c and mitochondria
13. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
14. Erythropoietin: A model system for studying oxygen-dependent gene regulation
15. Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes
16. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation
17. Regulation of cell death protease caspase-9 by phosphorylation
18. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin
19. Phosphatidylserine-dependent phagocytosis of apoptotic glioma cells by normal human microglia, astrocytes, and glioma cells
20. SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells
21. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L)
22. Erythropoietin prevents ischemic neuronal apoptosis through the serine-threonine kinase Akt1 and cytochrome c release
23. Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury
24. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
25. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential
26. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling
27. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades
28. Localization of specific erythropoietin binding sites in defined areas of the mouse brain
29. Two splice variants of the hypoxia-inducible factor HIF-1 alpha as potential dimerization partners of ARNT2 in neurons
30. Characterization of recombinant monkey and human erythropoietin
31. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells
32. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis
33. Receptor-binding, tyrosine phosphorylation and chromosome localization of the mouse SH2-containing phosphotyrosine phosphatase Syp
34. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons
35. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation
36. Apoptotic pathways: Paper wraps stone blunts scissors
37. The roles of Bc1-X(L) and apopain in the control of erythropoiesis by erythropoietin
38. Reduction of ischemic damage in NGF-transgenic mice: Correlation with enhancement of antioxidant enzyme activities
39. p38 kinase is activated in the Alzheimer's disease brain
40. A novel role for protein tyrosine phosphatase shp1 in controlling glial activation in the normal and injured nervous system
41. 2-dependent degradation domain via the ubiquitin-proteasome pathway
42. Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide: Implications for oxygen sensing and signaling
43. JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells
44. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB
45. Erythropoietin: Structure, control of production, and function
46. Direct association with and dephosphorylation of Jak2 kinase by the SH2- domain-containing protein tyrosine phosphatase SHP-1
47. Neuronal apoptosis: Current understanding of molecular mechanisms and potential role in ischemic brain injury
48. Mitogenic signaling and inhibition of apoptosis via the erythropoietin receptor box-1 domain
49. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain
50. Beta-Amyloid peptide-induced apoptosis regulated by a novel protein containing a g protein activation module
51. Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria
52. Involvement of caspase 3 in apoptotic death of cortical neurons evoked by DNA damage
53. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
54. Abnormal chemokine-induced responses of immature and mature hematopoietic cells from motheaten mice implicate the protein tyrosine phosphatase SHP-1 in chemokine responses
55. Mechanism of UV-induced apoptosis in human leukemia cells: Roles of Ca2+/Mg(2+)-dependent endonuclease, caspase-3, and stress-activated protein kinases
56. GM-CSF rescues TF-1 cells from growth factor withdrawal-induced, but not differentiation-induced apoptosis: The role of BCL-2 and MCL-1
57. Synergetic activation of p38 mitogen-activated protein kinase and caspase-3-like proteases for execution of calyculin A-induced apoptosis but not N-methyl-D-aspartate-induced necrosis in mouse cortical neurons
58. Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase
59. Erythropoietin
60. Mitochondrial control of cell death
61. Life-or-death decisions
62. Survival of hippocampal neurons in culture upon hypoxia: Effect of erythropoietin
63. Endonuclease G is an apoptotic DNase when released from mitochondria
64. The metabotropic glutamate receptor system protects against ischemic free radical programmed cell death in rat brain endothelial cells
65. Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death
66. Erythropoietin for the treatment of anemia associated with hematological malignancy
67. Neuronal death in brain infarcts in man
68. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: Differential requirements for caspase activation
69. The dynamics of cellular injury: Transformation into neuronal and vascular protection
70. Membrane asymmetry and DNA degradation: Functionally distinct determinants of neuronal programmed cell death
71. Metabotropic glutamate receptor subtypes independently modulate neuronal intracellular calcium
72. Elucidating neuronal and vascular injury through the cytoprotective agent nicotinamide
73. Erythropoietin gene expression in human, monkey and murine brain
74. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
75. Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor
76. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death
77. The erythropoietin receptor
78. Bcl-2 and Ca(2+)-mediated mitochondrial dysfunction in neural cell death
79. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis
80. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation
81. TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3′-kinase/protein kinase B signaling pathway
82. Internucleosomal DNA cleavage involved in ischemia-induced neuronal death
83. Checkpoints of dueling dimers foil death wishes
84. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling
85. Apoptosis-regulating proteins as targets for drug discovery
86. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling
87. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery
88. In vivo evidence that erythropoietin protects neurons from ischemic damage
89. Erythropoietin: Multiple physiological functions and regulation of biosynthesis
90. Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury
91. Recognition and phagocytosis of cells undergoing apoptosis
92. Receptor-like protein tyrosine phosphatases: Alike and yet so different
93. Apoptosis in Alzheimer's disease - An update
94. L and Bcl-2
95. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain
96. Serial killers: Ordering caspase activation events in apoptosis
97. -/- mice: A direct role for Stat5 in Bcl-X(L) induction
98. -/-) mice due to decreased survival of early erythroblasts
99. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia
100. Localization and subcellular distribution of SH-PTP2, a protein-tyrosine phosphatase with Src homology-2 domains, in rat brain
101. Endonuclease activation following focal ischemic injury in the rat brain
102. Effect of active oxygen radicals on protein and carbohydrate moieties of recombinant human erythropoietin
103. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors
104. Direct temporal analysis of apoptosis induction in living adherent neurons
105. Nitric oxide induction of neuronal endonuclease activity in programmed cell death
106. Metabotropic glutamate receptors prevent programmed cell death through the modulation of neuronal endonuclease activity and intracellular pH
107. Neuronal intracellular pH directly mediates nitric oxide-induced programmed cell death
108. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAPI and c-IAP2 to suppress caspase-8 activation
109. Some chemical properties of human erythropoietin
110. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin
111. Suicidal tendencies: Apoptotic cell death by caspase family proteinases
112. Caspase activation and cytochrome c release during HL-60 cell apoptosis induced by a nitric oxide donor
113. Proteintyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling
114. Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis
115. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis
116. Positive effects of SH2 domain-containing tyrosine phosphatase SHP-1 on epidermal growth factor- and interferon-gamma-stimulated activation of STAT transcription factors in HeLa cells
117. Transcriptional repression by RBE2F and regulation of anchorage-independent survival
118. TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells: Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease
119. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45
120. Akt regulates cell survival and apoptosis at a postmitochondrial level
121. Erythropoietin-dependent inhibition of apoptosis is supported by carboxyl-truncated receptor forms and blocked by dominant-negative forms of Jak2